New, more maneuverable unit joins competitors in better designed, mobile x-ray.
Carestream now has U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System.
Carestream put the mobile x-ray front and center at RSNA 2011, but now can take orders in the US.
The unit touts a wireless detector that can be used in other Carestream unites in a hospital to improve efficiency.
It also hosts software meant to help a radiographer quickly and accurately align the top tube with a grid for better image quality.
The top column is collapsible and a dual-drive systems enables the unit to make tight turns without strain on staff. The DRX-Revolution also offers a long tube head reach, so radiographers can conduct X-ray exams in crowded spots.
It will compete with other entries in the mobile x-ray market, such as Siemens Mobilett Mira Mobile Digital X-Ray System.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.